Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck

Japanese Journal of Clinical Oncology

Volumn 30, Issue 6, 2000, Pages 253-258

  Kohno, Naoyuki ^a   Ikari, Taketsugu ^b   Kawaida, Masahiro ^b   Tanaka, Kazuhito ^c   Kawaura, Mitsuhiro ^d   Kano, Shigeru ^e   Nakamizo, Munenaga ^f  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c AKITA UNIVERSITY   (Japan)

^d Keiyu Hospital   (Japan)

^e National Hospital Organization Tochigi Medical Center   (Japan)

^f Nihon Medical University Hospital   (Japan)

Author keywords

Cisplatin; Neoadjuvant chemotherapy; Randomized trial; Resectable head and neck cancer

Indexed keywords

CISPLATIN; ETOPOSIDE; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTICENTER STUDY; PHARYNX CARCINOMA; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TOXICITY; TREATMENT FAILURE;

EID: 0033854922     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyd071     Document Type: Article

References (22)

1. Head and neck cancer
2. Combined modality therapy of head and neck cancer
3. Overview of combined modality therapy for head and neck cancer
4. Cisplatin and 5-FU infusion chemotherapy in advanced recurrent cancer of the head and neck
5. Integration of chemotherapy into the combined modality therapy of head and neck squamous cancer
6. Final Report of the Head and Neck Contracts Program. Adjuvant chemotherapy for head and neck squamous carcinoma
7. Induction chemotherapy in advanced head and neck cancer: A radiation therapy oncology group study
8. Adjuvant chemotherapy in head and neck cancer
9. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer
10. Theoretical considerations regarding the early use of adjuvant chemotherapy
11. Clinical and scientific considerations in preoperative (neoadjuvant) chemotherapy
12. Reporting results of cancer treatment
13. Cisplatin and 5-flourouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
14. Salvage chemotherapy with Pem and long-CF regimen in CDDP refractory advanced head and neck cancer
15. Induction chemotherapy with cisplatin, etoposide and mitomycin-C (PEM) regimen in advanced cases with cancer of the pharynx and the oral cavity
16. Summary of proceedings of United States and Japan head and neck cancer clinical trial summit
17. Methodologic guideline for reports of clinical trials
18. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study of the Gruppo di Studio sui Tumori della Testa e del Collo
19. Sample size requirements for evaluating a conservative therapy
20. Sample size needed for a clinical trial
21. Locally advanced (stage III and IV) head and neck cancer; Westmead Hospital Experience